In the High Court of Justice (Chancery Division) Manchester.

In the matter of Optibiotix Health Plc (company number 05880755) with its registered office at Innovation Centre Innovation Way, Heslington, York, England, YO10 5DG (the Company).

Notice is hereby given that, on 27 July 2017, an application was presented to the High Court of Justice for an order to approve the cancellation and resulting reduction of:

• the entire 26,001,739 issued A deferred shares of £0.19 each in the capital of the Company;

• the entire 63,373,961 issued B deferred shares of £0.009 each in the capital of the Company; and

• the entire 135,587,295 issued C deferred shares of £0.0009 each in the capital of the Company,

which was approved by a special resolution passed at an Annual General Meeting held on 10 May 2016.

An order was pronounced by the High Court of Justice that the hearing be advertised in the London Gazette and that any person or body wishing to object to the order shall file and serve evidence in support of such objection by 4pm on 29 September 2017. In accordance with its practice, the Court is also likely to consider any other objections which are made to it, in writing or in person, at the hearing of the order to confirm the reduction of capital. That hearing is expected to take place at the Court on 23 October 2017 at 10:30am. Should that date change, the new date will be advertised on the website of the Company.

A copy of the Claim Form may be obtained from the Company’s Solicitors, Turner Parkinson LLP, Hollins Chambers, 64a Bridge Street, Manchester, M3 3BA, telephone number 0161 957 8888 (Ref: RPT/LC/8954-06).